WHO ICTRP trial
Development of a platform of Patient Derived Xenografts (PDX) and 2D/3D cell…
NL-OMON47127 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON47127 |
|---|---|
| Public title | Development of a platform of Patient Derived Xenografts (PDX) and 2D/3D cell cultures of Soft Tissue Sarcomas (STS): Protocol to obtain tumour material from patients with (non)-metastatic sarcomas. |
| Scientific title | Development of a platform of Patient Derived Xenografts (PDX) and 2D/3D cell cultures of Soft Tissue Sarcomas (STS): Protocol to obtain tumour material from patients with (non)-metastatic sarcomas. - Sarcoma PDX |
| Primary sponsor | Antoni van Leeuwenhoek Ziekenhuis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | soft tissue sarcoma;10028389;10027655;soft tissue sarcoma |
| Interventions | ;2D/3D cell cultures;response evaluation;Sarcoma |
| Registration date | Feb 16, 2018 |
| Target size | 40 |
| Secondary IDs | NCT02910895;NL58626.031.16 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: